Abstract

Reactive oxygen species (ROS) play an essential role in regulating various physiological functions of living organisms; however, as the concentration of ROS increases in the area of a lesion, this may undermine cellular homeostasis, leading to a series of diseases. Using cell-product species as triggers for targeted regulation of polymer structures and activity represents a promising approach for the treatment. ROS-responsive polymer carriers allow the targeted delivery of drugs, reduce toxicity and side effects on normal cells, and control the release of drugs, which are all advantages compared with traditional small-molecule chemotherapy agents. These formulations have attracted great interest due to their potential applications in biomedicine. In this review, recent progresses on ROS responsive polymer carriers are summarized, with a focus on the chemical mechanism of ROS-responsive polymers and the design of molecular structures for targeted drug delivery and controlled drug release. Meanwhile, we discuss the challenges and future prospects of its applications.

Highlights

  • Reactive oxygen species (ROS) play an essential role in regulating various physiological functions of living organisms; as the concentration of ROS increases in the area of a lesion, this may undermine cellular homeostasis, leading to a series of diseases

  • ROS-responsive polymer carriers allow the targeted delivery of drugs, reduce toxicity and side effects on normal cells, and control the release of drugs, which are all advantages compared with traditional smallmolecule chemotherapy agents

  • ROS-responsive polymers for drug delivery systems have been recognized as a valuable strategy to control drug delivery with low toxicity

Read more

Summary

Reactive Oxygen Species Responsive Polymers for Drug Delivery Systems

ROS-responsive polymer carriers allow the targeted delivery of drugs, reduce toxicity and side effects on normal cells, and control the release of drugs, which are all advantages compared with traditional smallmolecule chemotherapy agents. These formulations have attracted great interest due to their potential applications in biomedicine. It is possible to introduce specific functional groups or multiple groups on the polymer chains, and formulate multifunctional targets to achieve personalized therapy.

Aryl oxalate ester Proline oligomer
OTHER POLYMER SYSTEMS
Proline Oligomer
Findings
CONCLUSION AND FUTURE CHALLENGES
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.